


































hJournal of Cardiology Cases 9 (2014) 94–97
Contents lists available at www.sciencedirect.com
Journal  of  Cardiology  Cases
j ourna l h omepa ge: www.elsev ier .com/ locate / j ccase
ase  Report
echanical  clot  fragmentation  using  a  Swan–Ganz  catheter  is  useful
or  acute  massive  pulmonary  thromboembolism
itoshi  Mori  (MD),  Kikuo  Isoda  (MD,  PhD,  FJCC) ∗,  Toyokazu  Kimura  (MD),
oji Akita  (MD),  Takeshi  Adachi  (MD,  PhD,  FJCC)
nternal Medicine 1, National Defense Medical College, 3-2 Namiki, Tokorozawa, Saitama 359-8513, Japan
 r  t  i  c  l e  i  n  f  o
rticle history:
eceived 17 June 2013
eceived  in revised form 1 October 2013
ccepted 15 October 2013
a  b  s  t  r  a  c  t
Massive  pulmonary  thromboembolism  (PE) is an  acute-onset,  life-threatening  disease  in the  periopera-
tive  period.  Massive  PE led to  severe  hypoxemia  and  cor pulmonale  in  our patient  who  had  undergone
an  operation  for  thalamic  hemorrhage.  Mechanical  clot  fragmentation  using  a Swan–Ganz  catheter  was
attempted,  because  thrombolytic  therapy  was  contraindicated  for  our patient.  This  procedure  was  suc-eywords:
ulmonary thromboembolism
echanical  clot fragmentation
wan–Ganz  catheter
cessful,  resulting  in a decrease  in  pulmonary  artery  pressure  with  improvement  in hypoxemia.  Thus,  this
procedure  may  be useful  for patients  with  massive  PE  with  contraindications  to  thrombolytic  therapy.
<Learning objective:  Here  we present  the  usefulness  of mechanical  clot  fragmentation  using  a
Swan–Ganz  catheter  for a  patient  with  massive  pulmonary  thromboembolism  (PE)  with  contraindica-
tions  to thrombolytic  therapy.  This  case  suggests  that  the  procedure  may  be a promising  method  for
reducing  pulmonary  artery  pressure  and improving  hypoxemia  in  patients  with  massive  PE.>
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Massive pulmonary thromboembolism (PE) is a life-threatening
isease, and thrombolytic therapy should be considered for
atients with massive PE who have hypotension, severe hypox-
mia, or heart failure [1,2]. However, the indications for
hrombolytic therapy are limited because of its hemorrhagic com-
lications [2]. Here we present the usefulness of mechanical clot
ragmentation using a Swan–Ganz catheter (SGC) for a massive PE
atient with contraindications to thrombolytic therapy.
ase  report
A 47-year-old man, who  had undergone an operation for tha-
amic hemorrhage, developed acute hypoxemia after a few hours
f extubation and the neurosurgeon referred him to us. The patient
ith a decreased level of consciousness had leakage of stool. He had
hown anisocoria (left: 4 mm,  right: 3 mm)  since the operation, but
ight reﬂex was normal. Cardiac examination demonstrated tachy-
ardia, the presence of systolic murmur (Levine III/VI), and a third
eart sound at the left lower sternal border, and a right ventricular
eave. On physical examination, his blood pressure was decreased
rom 210/110 mmHg  to 138/80 mmHg, pulse was 138/min, and
xygen saturation was 60% during administration of 100% oxygen
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through a rebreathing mask. Electrocardiograph showed sinus
tachycardia and left ventricular hypertrophy (Fig. 1A). After reintu-
bation, chest radiograph indicated that the cardiothoracic ratio was
increased (59%) with enlargement of pulmonary arteries (Fig. 1B).
Transthoracic echocardiography demonstrated a right ventricular
dilatation with paradoxical movement of interventricular septum.
Table 1 shows the blood sample data. Laboratory examination
revealed high levels of serum d-dimer (28.1 g/ml) and severe
hypoxemia [PO2 of 46.2 mmHg  and PCO2 of 45.4 mmHg (FiO2
1.0)]. Heparin anticoagulation therapy was  administered (3000 U iv
and 15,000 U/day) and activated partial thromboplastin time (aPTT)
was kept between 61 and 75 s. A 7 French (Fr) SGC  was advanced
into the main pulmonary artery via the right internal jugular vein.
Pulmonary arteriography (PAG) demonstrated subtotal occlusion
of both left (Fig. 2A) and right pulmonary arteries and pressure
study using SGC showed mean pulmonary arterial pressure was
63 mmHg  (Fig. 3). Although thrombolytic therapy should be con-
sidered for our patient with massive PE, we  could not perform it
because he had undergone the operation for thalamic hemorrhage
within a few days. After obtaining informed consent from his fam-
ily, we attempted mechanical clot fragmentation using a SGC. The
SGC balloon was safely directed to the target lesions using a steer-
able Radifocus guide wire (Terumo, Tokyo, Japan). We  inﬂated the
balloon several sites from the pulmonary trunks to both proximal
inferior pulmonary arteries, and proximal of upper lobe branch,
but not in other lobar or segmental arteries. Different angiographic
views were mandatory to check the position and to be sure that
the balloon was  in one of those positions. We,  thus, checked the
vier Ltd. All rights reserved.
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Fig. 1. (A) Electrocardiograph showed sinus tachycardia and left ventricular hypertroph




WBC  17,000/l, Hb 15.8 g/dl, Plt 28.5/l
Clotting function test
APTT 39.5 s, PT-INR 1.12, Fbg 551 mg/dl, FDP 71 g/ml, d-dimer
28.1  g/ml
Biochemical  examination
T-bil  0.7 mg/dl, AST/ALT 29/55 IU/l, LDH 254 IU/l, TP/Alb 6.5/3.4 g/dl, BUN
30 mg/dl, Cre 1.62 mg/dl, CK 135 IU/l, Na 141 mequiv/l, K 4.2 mequiv/l, Cl
105  mequiv/l, CRP2.0 mg/dl
Arterial blood gas measurement (FiO2 1.0)
pH  7.317, PaCO2 45.4 mmHg, PaO2 46.2 mmHg, HCO3− 23.4 mmol/l, BE
−0.2 mmol/l
WBC, white blood cell; Hb, hemoglobin; Plt, platelet; APTT, activated partial throm-
boplastin time; PT-INR, prothrombin time-international normalized ratio; Fbg,
ﬁbrinogen; FDP, ﬁbrin/ﬁbrinogen degradation products; T-bil, total bilirubin; AST,
























tion therapy with warfarin [6]. Indeed, in our patient, the distalenase; TP, total protein; Alb, albumin; BUN, blood urea nitrogen; Cre, creatinine;
K,  creatine phosphokinase; CRP, C-reactive protein; BE, base excess.
alloon had not migrated into a distal position in the pulmonary
rtery. Finally, the balloon was inﬂated several times (5–10 times)
ith 1.5 ml  air by hand in the clots (Fig. 2B). The inﬂation time was
ithin 1 s and the purpose of this procedure was clot fragmenta-
ion, not compression of them. A PAG taken after mechanical clot
ragmentation showed several residual thrombi remaining in the
ulmonary arteries, but re-establishment of blood ﬂow to segmen-
al branches was evident (Fig. 2C). Mean pulmonary pressure fell
o 33 mmHg  (Fig. 3), and oxygen saturation increased from 78%
o 90% (FiO2 1.0). After clot fragmentation, a venography revealed
hat there were no residual thrombi in femoral veins, iliac veins, or
nferior vena cava (IVC). Thus, we did not use an IVC ﬁlter for our
atient.
The patient started taking warfarin sodium (3 mg/day) on the
th postoperative day. Contrast-enhanced multi-slice computed
omography (MSCT) was performed on the 7th postoperative day,
nd demonstrated residual central thrombi within both the left and
ight pulmonary arteries (Fig. 4A). We  continued to give him war-
arin (3.5 mg/day) and heparin (25,000 units per day) for keeping
–3-fold aPTT compared with normal control. When international
ormalized ratio levels reached more than 2.0, we  stopped giv-
ng him heparin. His PaO2/FiO2 ratio was improved gradually, andy. (B) Chest X-ray indicated that the cardiothoracic ratio was increased (59%) with
he  could sit on the chair and was  moved to the general ward on
the 18th postoperative day. He underwent rehabilitation and could
stand up by himself on the 27th postoperative day. Finally, he could
walk by himself on the 33rd postoperative day. MSCT on the 33rd
postoperative day detected only few ﬁlling defects within both pul-
monary arteries (Fig. 4B), pressure study using a SGC on the 44th
postoperative day revealed his mean pulmonary pressure fell to
15 mmHg  (Fig. 3). He was discharged on the 52nd postoperative
day.
Discussion
Acute massive PE is a clinical emergency that requires imme-
diate and effective life-supporting therapies. Anticoagulation is
the most traditional treatment for PE, but is not sufﬁcient for
all patients with massive PE. Thrombolytic therapy is guideline-
recommended treatment for patients with massive PE who
have hypotension, severe hypoxemia, or heart failure [3]. How-
ever, thrombolytic therapy was contraindicated for our patient,
because he had undergone the operation for thalamic hemor-
rhage within a few days. Then, mechanical clot fragmentation
using a SGC was  attempted, and this procedure was successful,
resulting in a decrease in pulmonary artery pressure with improve-
ment in hypoxemia. Although different devices for mechanical
thrombectomy are available (such as pigtail catheter, guide
wire, percutaneous transluminal angioplasty balloon, and special
thrombofragmentation devices) [4,5], this is the ﬁrst report to
demonstrate that mechanical clot fragmentation using a SGC may
be useful for patients with massive PE with contraindications to
thrombolytic therapy.
Mechanical  clot fragmentation reduces the thrombus burden
in the main pulmonary arteries, and prevents death due to right
heart failure by prompt peripheral dispersal of the central throm-
bus, resulting in a decrease in pulmonary artery resistance with
improvement in pulmonary ﬂow. Fragmentation also leads to
amplifying the surface area available for effective anticoagula-microemboli resulting from the clot fragmentation procedure were
subsequently dissipated by anticoagulation therapy with warfarin,
so that MSCT on the 33rd postoperative day detected only few ﬁlling
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Fig. 2. (A) Pulmonary arteriography (PAG) demonstrated subtotal occlusion of left pulmonary artery. Red arrows indicate thrombi. (B) The balloon of Swan–Ganz catheter
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cSGC) was inﬂated several times in the clots of left pulmonary artery. Yellow arrow
everal residual thrombi remaining in the pulmonary arteries, but re-establishment
For  interpretation of the references to color in this ﬁgure legend, the reader is refe
efects within both pulmonary arteries, and later PO2 had increased
nd supplemental oxygen was no longer needed.
As mentioned above, different devices for mechanical
hrombectomy are available [4,5], however the careful use of
 SGC may  be associated with the lowest risk of physical injury
ecause SGCs are designed for use even in healthy persons, unlike
ther modalities. We  have also used an 8 Fr guiding catheter for
spiration of thrombi since 1996 [5], however, this procedure could
reate only a small cannel in the clot and was often unsuccessful for
Fig. 3. The summary of clinical course of the patient. P/F ratio, Picate balloon of SGC. (C) A PAG taken after mechanical clot fragmentation showed
od ﬂow to segmental branches was evident. Red arrows indicate moderate thrombi.
 the web  version of the article.)
improvement of pulmonary hypertension or hypoxemia. On the
other hand, clot fragmentation using SGC has created many cannels
in the clots, resulting in reduced pulmonary artery pressure and
improving hypoxemia. Moreover, a SGC possesses further advan-
tages in that it was widely available and at a relatively low cost,
especially when compared to mechanically driven thrombectomy
devices. Furthermore, clot fragmentation using a SGC has added
advantage of offering a dynamic overview of treatment success by
both PAG and checking pulmonary artery pressure. Indeed, in our
aO2/FiO2 ratio; mPAP, mean pulmonary artery pressure.







































[7]  Hardy JF, Taillefer J. Inﬂating characteristics of Swan–Ganz catheter balloons:ig. 4. Contrast-enhanced multi-slice computed tomography (MSCT) on the 7th p
ulmonary arteries (A). MSCT on the 33rd postoperative day detected only few ﬁlli
ase, a PAG using a SGC showed several residual thrombi remaining
n the pulmonary arteries, but re-establishment of blood ﬂow to
egmental branches was evident, and pressure study revealed
ean pulmonary arterial pressure decreased from 63 mmHg  to
3 mmHg. These ﬁndings could allow real-time decision making
o optimize recanalization.
There  may  be some complications associated with the proce-
ure. One of the most critical complications is pulmonary artery
erforation. This complication may  occur during balloon inﬂa-
ion that has inadvertently migrated into a distal position in the
ulmonary artery. However, we believe this complication can be
voided by careful attention to the balloon position. We  can check
he position seeing the course of guide wire under the differ-
nt angiographic views, and know whether the balloon is in the
osition mentioned above. This position-checking method looks
emarkably similar to the percutaneous coronary intervention for
cute myocardial infarction, because we usually try to know the
alloon position according to the course of the guide wire. Thus,
e have never inﬂated the balloon in the distal position in the pul-
onary artery, and pulmonary artery perforation has not occurred
n 11 consecutive massive PE patients (including this case). Another
ritical complication may  be balloon rupture. However, we think
his complication may  be rare, because the balloon of SGC can gen-
rate a maximum of only 0.66 atm with the simple compression
f 1.5 ml  of air [7] and it always has a large indentation rather
han overstretch in the solid organized thrombus. If perchance bal-
oon rupture occurs, we could aspirate the air using catheter [8]
ith relative ease because pulmonary circulation is stagnant in PE
atients.
In conclusion, mechanical clot fragmentation using a SGC was
ttempted for our patient with massive PE. This procedure was  suc-
essful, resulting in a decrease in pulmonary artery pressure with
[erative day demonstrated residual central thrombi within both the left and right
ects within both pulmonary arteries (B).
improvement  in hypoxemia. Thus, mechanical clot fragmentation
using a SGC may  be a promising method for reducing pulmonary
artery pressure and improving hypoxemia in massive PE patients
with contraindications to thrombolytic therapy.
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